Moreover, alterations in miR-132 and miR-124 values in non-treated and citalopram-treated patients with depression have shown that enhancement of both miRNAs increases plasma BDNF values (Fig. 1) [207]. This evidence concerns the gene BDNF and depressive symptom measurement.